Lindsay A Bornheimer1. 1. Brown School of Social Work, Washington University in St. Louis, United States; McSilver Institute for Poverty Policy and Research, New York University, 20 Cooper Square, 2nd Floor, New York, NY 10003, United States. Electronic address: Lindsay.bornheimer@nyu.edu.
Abstract
BACKGROUND: Suicide is among the leading causes of death for adults diagnosed with schizophrenia, with risk estimates being over eight folds greater than the general population. While the majority of research to date focuses on the role of symptoms of depression in suicide risk, there is a lack of consensus and understanding of the relationship between positive symptoms of psychosis and both suicidal ideation and attempt. The current study examined pathways of influence between symptoms of depression, positive symptoms of psychosis (i.e. hallucinations and delusions), hopelessness, and suicidal ideation among a population of adults diagnosed with schizophrenia. METHODS: Data were obtained from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE; n=1460) at baseline. Suicidal ideation, hopelessness, and symptoms of depression were measured by the Calgary Depression Scale (CDRS) and hallucinations and delusions by the Positive and Negative Syndrome Scale (PANSS). Data were analyzed with Structural Equation Modeling (SEM) using Mplus 7. RESULTS:Symptoms of depression, positive symptoms of psychosis, and hopelessness independently predicted suicidal ideation. Hopelessness significantly mediated the relationship between symptoms of depression and suicidal ideation. Lastly, positive symptoms of psychosis were found to moderate the relationship between symptoms of depression and suicidal ideation. CONCLUSIONS: The current study provides evidence for the role that positive symptoms of psychosis (specifically hallucinations and delusions) play in suicidal ideation, pointing towards the implication that beyond symptoms of depression, positive symptoms must be evaluated for and treated.
RCT Entities:
BACKGROUND: Suicide is among the leading causes of death for adults diagnosed with schizophrenia, with risk estimates being over eight folds greater than the general population. While the majority of research to date focuses on the role of symptoms of depression in suicide risk, there is a lack of consensus and understanding of the relationship between positive symptoms of psychosis and both suicidal ideation and attempt. The current study examined pathways of influence between symptoms of depression, positive symptoms of psychosis (i.e. hallucinations and delusions), hopelessness, and suicidal ideation among a population of adults diagnosed with schizophrenia. METHODS: Data were obtained from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE; n=1460) at baseline. Suicidal ideation, hopelessness, and symptoms of depression were measured by the Calgary Depression Scale (CDRS) and hallucinations and delusions by the Positive and Negative Syndrome Scale (PANSS). Data were analyzed with Structural Equation Modeling (SEM) using Mplus 7. RESULTS: Symptoms of depression, positive symptoms of psychosis, and hopelessness independently predicted suicidal ideation. Hopelessness significantly mediated the relationship between symptoms of depression and suicidal ideation. Lastly, positive symptoms of psychosis were found to moderate the relationship between symptoms of depression and suicidal ideation. CONCLUSIONS: The current study provides evidence for the role that positive symptoms of psychosis (specifically hallucinations and delusions) play in suicidal ideation, pointing towards the implication that beyond symptoms of depression, positive symptoms must be evaluated for and treated.
Authors: Thomas E Joiner; Yeates Conwell; Kathleen Kara Fitzpatrick; Tracy K Witte; Norman B Schmidt; Marcelo T Berlim; Marcelo P A Fleck; M David Rudd Journal: J Abnorm Psychol Date: 2005-05
Authors: Jill M Harkavy-Friedman; David Kimhy; Elizabeth A Nelson; David F Venarde; Dolores Malaspina; J John Mann Journal: J Clin Psychiatry Date: 2003-08 Impact factor: 4.384
Authors: Lindsay A Bornheimer; Juliann Li Verdugo; Joshua Holzworth; Vitalis Im; Fonda N Smith; Hannah Sliwa; Stephan F Taylor; Cheryl A King; Timothy Florence; Nicholas Tarrier; Joseph A Himle Journal: Psychiatry Res Date: 2022-03-07 Impact factor: 11.225
Authors: Lindsay A Bornheimer; Jessica A Wojtalik; Juliann Li; Derin Cobia; Matthew J Smith Journal: Schizophr Res Date: 2021-01-23 Impact factor: 4.939
Authors: Yicheng Long; Xuan Ouyang; Zhening Liu; Xudong Chen; Xinran Hu; Edwin Lee; Eric Y H Chen; Weidan Pu; Baoci Shan; Robert M Rohrbaugh Journal: Front Psychiatry Date: 2018-08-28 Impact factor: 4.157
Authors: Kate Haining; Olga Karagiorgou; Ruchika Gajwani; Joachim Gross; Andrew I Gumley; Stephen M Lawrie; Matthias Schwannauer; Frauke Schultze-Lutter; Peter J Uhlhaas Journal: Early Interv Psychiatry Date: 2020-12-28 Impact factor: 2.721